Description
Retatrutide (GEN-HEALTH® Elite-Line) is a next-generation single peptide agonist targeting three hormone receptors: glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon receptors. Formulated to high analytical purity (HPLC ≥ 98.9%) for laboratory research, calibration assays, and metabolic pathways studies, this triple-agonist mechanism acts on key systems involved in energy expenditure and glucose homeostasis. Supplied as a certified reference material (CRM) in a sterile, dual-chamber prefilled pen delivering 60 mg per pen (1 click = 0.5 mg), integrating lyophilized peptide and diluent for on-demand reconstitution.
Reviews
There are no reviews yet.